Computational structure‐based drug design: Predicting target flexibility

The role of molecular modeling in drug design has experienced a significant revamp in the last decade. The increase in computational resources and molecular models, along with software developments, is finally introducing a competitive advantage in early phases of drug discovery. Medium and small companies with strong focus on computational chemistry are being created, some of them having introduced important leads in drug design pipelines. An important source for this success is the extraordinary development of faster and more efficient techniques for describing flexibility in three‐dimensional structural molecular modeling. At different levels, from docking techniques to atomistic molecular dynamics, conformational sampling between receptor and drug results in improved predictions, such as screening enrichment, discovery of transient cavities, etc. In this review article we perform an extensive analysis of these modeling techniques, dividing them into high and low throughput, and emphasizing in their application to drug design studies. We finalize the review with a section describing our Monte Carlo method, PELE, recently highlighted as an outstanding advance in an international blind competition and industrial benchmarks.We acknowledge the BSC-CRG-IRB Joint Research Program in Computational Biology. This work was supported by a grant from the Spanish Government CTQ2016-79138-R.J.I. acknowledges support from SVP-2014-068797, awarded by the Spanish Government.Peer ReviewedPostprint (author's final draft

Structural Prediction of Protein–Protein Interactions by Docking: Application to Biomedical Problems

A huge amount of genetic information is available thanks to the recent advances in sequencing technologies and the larger computational capabilities, but the interpretation of such genetic data at phenotypic level remains elusive. One of the reasons is that proteins are not acting alone, but are specifically interacting with other proteins and biomolecules, forming intricate interaction networks that are essential for the majority of cell processes and pathological conditions. Thus, characterizing such interaction networks is an important step in understanding how information flows from gene to phenotype. Indeed, structural characterization of protein–protein interactions at atomic resolution has many applications in biomedicine, from diagnosis and vaccine design, to drug discovery. However, despite the advances of experimental structural determination, the number of interactions for which there is available structural data is still very small. In this context, a complementary approach is computational modeling of protein interactions by docking, which is usually composed of two major phases: (i) sampling of the possible binding modes between the interacting molecules and (ii) scoring for the identification of the correct orientations. In addition, prediction of interface and hot-spot residues is very useful in order to guide and interpret mutagenesis experiments, as well as to understand functional and mechanistic aspects of the interaction. Computational docking is already being applied to specific biomedical problems within the context of personalized medicine, for instance, helping to interpret pathological mutations involved in protein–protein interactions, or providing modeled structural data for drug discovery targeting protein–protein interactions.Spanish Ministry of Economy grant number BIO2016-79960-R; D.B.B. is supported by a predoctoral fellowship from CONACyT; M.R. is supported by an FPI fellowship from the Severo Ochoa program. We are grateful to the Joint BSC-CRG-IRB Programme in Computational Biology.Peer ReviewedPostprint (author's final draft

In silico assessment of potential druggable pockets on the surface of α1-Antitrypsin conformers

The search for druggable pockets on the surface of a protein is often performed on a single conformer, treated as a rigid body. Transient druggable pockets may be missed in this approach. Here, we describe a methodology for systematic in silico analysis of surface clefts across multiple conformers of the metastable protein α1-antitrypsin (A1AT). Pathological mutations disturb the conformational landscape of A1AT, triggering polymerisation that leads to emphysema and hepatic cirrhosis. Computational screens for small molecule inhibitors of polymerisation have generally focused on one major druggable site visible in all crystal structures of native A1AT. In an alternative approach, we scan all surface clefts observed in crystal structures of A1AT and in 100 computationally produced conformers, mimicking the native solution ensemble. We assess the persistence, variability and druggability of these pockets. Finally, we employ molecular docking using publicly available libraries of small molecules to explore scaffold preferences for each site. Our approach identifies a number of novel target sites for drug design. In particular one transient site shows favourable characteristics for druggability due to high enclosure and hydrophobicity. Hits against this and other druggable sites achieve docking scores corresponding to a Kd in the µM–nM range, comparing favourably with a recently identified promising lead. Preliminary ThermoFluor studies support the docking predictions. In conclusion, our strategy shows considerable promise compared with the conventional single pocket/single conformer approach to in silico screening. Our best-scoring ligands warrant further experimental investigation

BSP‐SLIM: A blind low‐resolution ligand‐protein docking approach using predicted protein structures

We developed BSP‐SLIM, a new method for ligand–protein blind docking using low‐resolution protein structures. For a given sequence, protein structures are first predicted by I‐TASSER; putative ligand binding sites are transferred from holo‐template structures which are analogous to the I‐TASSER models; ligand–protein docking conformations are then constructed by shape and chemical match of ligand with the negative image of binding pockets. BSP‐SLIM was tested on 71 ligand–protein complexes from the Astex diverse set where the protein structures were predicted by I‐TASSER with an average RMSD 2.92 Å on the binding residues. Using I‐TASSER models, the median ligand RMSD of BSP‐SLIM docking is 3.99 Å which is 5.94 Å lower than that by AutoDock; the median binding‐site error by BSP‐SLIM is 1.77 Å which is 6.23 Å lower than that by AutoDock and 3.43 Å lower than that by LIGSITE CSC . Compared to the models using crystal protein structures, the median ligand RMSD by BSP‐SLIM using I‐TASSER models increases by 0.87 Å, while that by AutoDock increases by 8.41 Å; the median binding‐site error by BSP‐SLIM increase by 0.69Å while that by AutoDock and LIGSITE CSC increases by 7.31 Å and 1.41 Å, respectively. As case studies, BSP‐SLIM was used in virtual screening for six target proteins, which prioritized actives of 25% and 50% in the top 9.2% and 17% of the library on average, respectively. These results demonstrate the usefulness of the template‐based coarse‐grained algorithms in the low‐resolution ligand–protein docking and drug‐screening. An on‐line BSP‐SLIM server is freely available at http://zhanglab.ccmb.med.umich.edu/BSP‐SLIM . Proteins 2012. © 2011 Wiley Periodicals, Inc.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/89455/1/23165_ftp.pd

Constrained optimization applied to multiscale integrative modeling

Multiscale integrative modeling stands at the intersection between experimental and computational techniques to predict the atomistic structures of important macromolecules. In the integrative modeling process, the experimental information is often integrated with energy potential and macromolecular substructures in order to derive realistic structural models. This heterogeneous information is often combined into a global objective function that quantifies the quality of the structural models and that is minimized through optimization. In order to balance the contribution of the relative terms concurring to the global function, weight constants are assigned to each term through a computationally demanding process. In order to alleviate this common issue, we suggest to switch from the traditional paradigm of using a single unconstrained global objective function to a constrained optimization scheme. The work presented in this thesis describes the different applications and methods associated with the development of a general constrained optimization protocol for multiscale integrative modeling. The initial implementation concerned the prediction of symmetric macromolecular assemblies throught the incorporation of a recent efficient constrained optimizer nicknamed mViE (memetic Viability Evolution) to our integrative modeling protocol power (parallel optimization workbench to enhance resolution). We tested this new approach through rigorous comparisons against other state-of-the-art integrative modeling methods on a benchmark set of solved symmetric macromolecular assemblies. In this process, we validated the robustness of the constrained optimization method by obtaining native-like structural models. This constrained optimization protocol was then applied to predict the structure of the elusive human Huntingtin protein. Due to the fact that little structural information was available when the project was initiated, we integrated information from secondary structure prediction and low-resolution experiments, in the form of cryo-electron microscopy maps and crosslinking mass spectrometry data, in order to derive a structural model of Huntingtin. The structure resulting from such integrative modeling approach was used to derive dynamic information about Huntingtin protein. At a finer level of resolution, the constrained optimization protocol was then applied to dock small molecules inside the binding site of protein targets. We converted the classical molecular docking problem from an unconstrained single objective optimization to a constrained one by extracting local and global constraints from pre-computed energy grids. The new approach was tested and validated on standard ligand-receptor benchmark sets widely used by the molecular docking community, and showed comparable results to state-of-the-art molecular docking programs. Altogether, the work presented in this thesis proposed improvements in the field of multiscale integrative modeling which are reflected both in the quality of the models returned by the new constrained optimization protocol and in the simpler way of treating the uncorrelated terms concurring to the global scoring scheme to estimate the quality of the models

Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview

Computational techniques have been applied in the drug discovery pipeline since the 1980s. Given the low computational resources of the time, the first molecular modeling strategies relied on a rigid view of the ligand-target binding process. During the years, the evolution of hardware technologies has gradually allowed simulating the dynamic nature of the binding event. In this work, we present an overview of the evolution of structure-based drug discovery techniques in the study of ligand-target recognition phenomenon, going from the static molecular docking toward enhanced molecular dynamics strategies

STRUCTURAL MODELING OF PROTEIN-PROTEIN INTERACTIONS USING MULTIPLE-CHAIN THREADING AND FRAGMENT ASSEMBLY

Since its birth, the study of protein structures has made progress with leaps and bounds. However, owing to the expenses and difficulties involved, the number of protein structures has not been able to catch up with the number of protein sequences and in fact has steadily lost ground. This necessitated the development of high-throughput but accurate computational algorithms capable of predicting the three dimensional structure of proteins from its amino acid sequence. While progress has been made in the realm of protein tertiary structure prediction, the advancement in protein quaternary structure prediction has been limited by the fact that the degree of freedom for protein complexes is even larger and even fewer number of protein complex structures are present in the PDB library. In fact, protein complex structure prediction till date has largely remained a docking problem where automated algorithms aim to predict the protein complex structure starting from the unbound crystal structure of its component subunits and thus has remained largely limited in terms of scope. Secondly, since docking essentially treats the unbound subunits as "rigid-bodies" it has limited accuracy when conformational change accompanies protein-protein interaction. In one of the first of its kind effort, this study aims for the development of protein complex structure algorithms which require only the amino acid sequence of the interacting subunits as input. The study aimed to adapt the best features of protein tertiary structure prediction including template detection and ab initio loop modeling and extend it for protein-protein complexes thus requiring simultaneous modeling of the three dimensional structure of the component subunits as well as ensuring the correct orientation of the chains at the protein-protein interface. Essentially, the algorithms are dependent on knowledge-based statistical potentials for both fold recognition and structure modeling. First, as a way to compare known structure of protein-protein complexes, a complex structure alignment program MM-align was developed. MM-align joins the chains of the complex structures to be aligned to form artificial monomers in every possible order. It then aligns them using a heuristic dynamic programming based approach using TM-score as the objective function. However, the traditional NW dynamic programming was redesigned to prevent the cross alignment of chains during the structure alignment process. Driven by the knowledge obtained from MM-align that protein complex structures share evolutionary relationships and the current protein complex structure library already contains homologous/structurally analogous protein quaternary structure families, a dimeric threading approach, COTH was designed. The new threading-recombination approach boosts the protein complex structure library by combining tertiary structure templates with complex alignments. The query sequences are first aligned to complex templates using the modified dynamic programming algorithm, guided by a number of predicted structural features including ab initio binding-site predictions. Finally, a template-based complex structure prediction approach, TACOS, was designed to build full-length protein complex structures starting from the initial templates identified by COTH. TACOS, fragments the templates aligned regions of templates and reassembles them while building the structure of the threading unaligned region ab inito using a replica-exchange monte-carlo simulation procedure. Simultaneously, TACOS also searches for the best orientation match of the component structures driven by a number of knowledge-based potential terms. Overall, TACOS presents the one of the first approach capable of predicting full length protein complex structures from sequence alone and introduces a new paradigm in the field of protein complex structure modeling

Plausible blockers of Spike RBD in SARS-CoV2-molecular design and underlying interaction dynamics from high-level structural descriptors

COVID-19 is characterized by an unprecedented abrupt increase in the viral transmission rate (SARS-CoV-2) relative to its pandemic evolutionary ancestor, SARS-CoV (2003). The complex molecular cascade of events related to the viral pathogenicity is triggered by the Spike protein upon interacting with the ACE2 receptor on human lung cells through its receptor binding domain (RBDSpike). One potential therapeutic strategy to combat COVID-19 could thus be limiting the infection by blocking this key interaction. In this current study, we adopt a protein design approach to predict and propose non-virulent structural mimics of the RBDSpike which can potentially serve as its competitive inhibitors in binding to ACE2. The RBDSpike is an independently foldable protein domain, resilient to conformational changes upon mutations and therefore an attractive target for strategic re-design. Interestingly, in spite of displaying an optimal shape fit between their interacting surfaces (attributed to a consequently high mutual affinity), the RBDSpike-ACE2 interaction appears to have a quasi-stable character due to a poor electrostatic match at their interface. Structural analyses of homologous protein complexes reveal that the ACE2 binding site of RBDSpike has an unusually high degree of solvent-exposed hydrophobic residues, attributed to key evolutionary changes, making it inherently "reaction-prone." The designed mimics aimed to block the viral entry by occupying the available binding sites on ACE2, are tested to have signatures of stable high-affinity binding with ACE2 (cross-validated by appropriate free energy estimates), overriding the native quasi-stable feature. The results show the apt of directly adapting natural examples in rational protein design, wherein, homology-based threading coupled with strategic "hydrophobic ↔ polar" mutations serve as a potential breakthrough